Acute Porphyria Drug Database

Monograph

A11CC02 - Dihydrotachysterol
Propably not porphyrinogenic
PNP

Rationale
RXR-ligand. Inducer of CYP 3A4. Administered only in ug quantities.
Chemical description
Vitamin D tablets 0.2 mg used for treatment of hyperparathyroidism, vitamin D-deficiency, steathorrea, osteomalacia. C.Andersson; patient reports: tolerated (n=1)

Similar drugs
Explore alternative drugs in similar therapeutic classes A11C / A11CC or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
United Kingdom
AT10 ยท AT10 250micrograms/ml oral solution
 
© NAPOS 2024
An unhandled error has occurred. Reload ๐Ÿ—™